Updates are available Correction dated 2026-02-28
Click to view Correction: https://doi.org/10.1007/s40123-026-01319-y
-
Authors
Tillmann, Anne
Stillenmunkes, Richard
Garweg, Justus G.
Cattaneo, Jennifer
Bartolomeo, Nicolò
Grimaldi, Gabriela
Spitznagel, Tahm
De Oliveira Figueiredo, Eva C.
Ambresin, Aude
Menghini, Moreno
Somfai, Gábor M.
Zweifel, Sandrine
Fröhlich, Jacqueline
Artemiev, Dmitri
Ebneter, Andreas
Hatz, Katja
Weinberger, Andreas
Pfister, Isabel B.
Schild, Christin
Eandi, Chiara
Munk, Marion R. https://orcid.org/0000-0002-6227-2242
,
Cozzi, Mariano
Feltgen, Nicolas
Schaerer, Nils
- License Information
-
More Information
Article History
Received: 11 August 2025
Accepted: 15 September 2025
First Online: 17 October 2025
Change Date: 9 February 2026
Change Type: Update
Change Details: The original online version of this article was revised due to incorrect figure legends in the article. Now, the figure legends has been corrected.
Change Date: 28 February 2026
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40123-026-01319-y
Declarations
:
: Gabriela Grimaldi: consultant for Apellis, Bayer, Roche. Lecturer for Abbvie, Apellis, Bayer, Roche. Grant support from Bayer and Roche. Gábor M. Somfai: consultant for Apellis, Allergan, Bayer, Novartis, Roche. Lecturer for Apellis, Allergan, Bayer, Novartis, Roche, Carl Zeiss Meditec. Justus G. Garweg: Consultancies and Lectures for AbbVie, Apellis, Bayer. Novartis, Roche Andreas Ebneter: Consultant for Apellis, Bayer, Roche, former employee of F. Hoffmann-La Roche Ltd. Andreas Weinberger: Consultancies and Lectures for Apellis, Bayer. Novartis, Roche Marion R. Munk: consultant for Apellis, Abbvie, Acuccela, Bayer, Roche, Lumithera, Novartis, Ocuterra, Alimera, Zeiss, Ocular therapeutix, Isarna, RetinAI, Dandelion, Optos, Oculis, Lumithera, Kubota, Eyepoint, Avecida Therapeutics, Astellas, Genesight Therapeutics. Anne Tillmann, Richard Stillenmunkes, Jennifer Cattaneo, Nicolò Bartolomeo, Tahm Spitznagel, Eva C De Oliveira Figueiredo, Aude Ambresin, Moreno Menghini, Sandrine Zweifel, Jacqueline Fröhlich, Dmitri Artemiev, Katja Hatz, Isabel B. Pfister, Chiara Eandi, Christin Schild has nothing to disclose.
: The study was approved by all participating ethics committees, led by the ethics committee of the canton of Berne (registration no. 2024-01026). Coded patient data were included on the basis of general or specific informed consent, in line with ICH-GCP E6, the Declaration of Helsinki, and Swiss law.
